Koyfin Home > Directory > Health Care > Horizon Therapeutics > Enterprise Value

Horizon Therapeutics Enterprise Value Chart (HZNP)

Horizon Therapeutics annual/quarterly Enterprise Value from 2011 to 2020.
  • Horizon Therapeutics Enterprise Value for the quarter ending November 11, 2020 was $14,870m a 2.06% increase of 307m year over year
  • Horizon Therapeutics Enterprise Value for the last 12 months ending November 11, 2020 was $14,870m a 2.06% increase of 307m year over year
  • Horizon Therapeutics Annual Enterprise Value for 2020 was $14,870m a -0.18% decrease of -26m from 2019
  • Horizon Therapeutics Annual Enterprise Value for 2020 was $14,897m a 2.44% increase of 364m from 2019
  • Horizon Therapeutics Annual Enterprise Value for 2020 was $14,533m a -0.21% decrease of -31m from 2019
Other Valuation Metrics:
  • Horizon Therapeutics Market Cap for the quarter ending March 03, 2018 was $2,337m a 17.35% increase of 406m year over year
  • Horizon Therapeutics Price / Book for the quarter ending March 03, 2018 was 2.36 a 32.03% increase of 0.75 year over year
View Chart On Koyfin

Quarterly HZNP Enterprise Value Data

11/2020$14,870m
11/2020$14,897m
11/2020$14,533m
11/2020$14,563m
11/2020$14,786m
11/2020$14,808m
11/2020$15,016m
11/2020$14,789m
11/2020$15,100m
11/2020$14,970m

Annual HZNP Enterprise Value Data

2020$14,870m
2020$14,897m
2020$14,533m
2020$14,563m
2020$14,786m
2020$14,808m
2020$15,016m
2020$14,789m
2020$15,100m
2020$14,970m